173 related articles for article (PubMed ID: 34228553)
21. Concurrent management of myopic choroidal neovascularization and rhegmatogenous retinal detachment with intravitreal antivascular endothelial growth factor during primary retinal detachment repair.
Saurabh K; Roy R; Thomas NR; Chowdhury M
Indian J Ophthalmol; 2018 Mar; 66(3):472-474. PubMed ID: 29480274
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor gene and the response to anti-vascular endothelial growth factor treatment for choroidal neovascularization in high myopia.
Miyake M; Yamashiro K; Akagi-Kurashige Y; Kumagai K; Nakata I; Nakanishi H; Oishi A; Tsujikawa A; Yamada R; Matsuda F; Yoshimura N
Ophthalmology; 2014 Jan; 121(1):225-233. PubMed ID: 23953100
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.
Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ
Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553
[TBL] [Abstract][Full Text] [Related]
24. Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre.
Rishi P; Rishi E; Bhende M; Agarwal V; Vyas CH; Valiveti M; Bhende P; Rao C; Susvar P; Sen P; Raman R; Khetan V; Murali V; Ratra D; Sharma T
Br J Ophthalmol; 2016 Oct; 100(10):1337-40. PubMed ID: 26792945
[TBL] [Abstract][Full Text] [Related]
25. Updates on the Management of Ocular Vasculopathies with VEGF Inhibitor Conbercept.
Liu H; Ma Y; Xu HC; Huang LY; Zhai LY; Zhang XR
Curr Eye Res; 2020 Dec; 45(12):1467-1476. PubMed ID: 32631094
[No Abstract] [Full Text] [Related]
26. Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia.
Ohno-Matsui K; Ikuno Y; Lai TYY; Gemmy Cheung CM
Prog Retin Eye Res; 2018 Mar; 63():92-106. PubMed ID: 29111299
[TBL] [Abstract][Full Text] [Related]
27. Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses.
Ruiz-Moreno JM; Montero JA; Amat-Peral P
Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):595-9. PubMed ID: 21234588
[TBL] [Abstract][Full Text] [Related]
28. [Research progress of treatment strategies for choroidal neovascularization secondary to pathological myopia].
Shi XH; Wei WB
Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):791-795. PubMed ID: 31607068
[TBL] [Abstract][Full Text] [Related]
29. Treatment of myopic choroidal neovascularization: a network meta-analysis and review.
Glachs L; Embacher S; Berghold A; Wildner B; Michelitsch M; Tscherne A; Wedrich A; Posch-Pertl L
Graefes Arch Clin Exp Ophthalmol; 2024 Jun; 262(6):1693-1722. PubMed ID: 37950753
[TBL] [Abstract][Full Text] [Related]
30. SUBRETINAL FIBROSIS AFTER ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EYES WITH MYOPIC CHOROIDAL NEOVASCULARIZATION.
Ahn SJ; Park KH; Woo SJ
Retina; 2016 Nov; 36(11):2140-2149. PubMed ID: 27124880
[TBL] [Abstract][Full Text] [Related]
31. Improved Visual Outcome and Low Recurrence with Early Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor in Myopic Choroidal Neovascularization.
Moon BG; Cho AR; Lee J; Kim YJ; Lee JY; Kim JG; Yoon YH
Ophthalmologica; 2017; 237(3):128-138. PubMed ID: 28278507
[TBL] [Abstract][Full Text] [Related]
32. Comparison of structural and functional outcome of aflibercept versus ranibizumab in patients with myopic choroidal neovascularization.
Howaidy A; Eldaly ZH
Eur J Ophthalmol; 2021 Jan; 31(1):211-217. PubMed ID: 31690105
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal aflibercept for myopic choroidal neovascularization.
Pece A
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1435. PubMed ID: 26851951
[No Abstract] [Full Text] [Related]
34. The correlation of atrophy, traction and neovascularization in myopic choroidal neovascularization according to a novel myopic maculopathy classification system (atrophy (A), traction (T), neovascularization (N): ATN).
Kurt RA; Sarıgül Sezenöz A; Akkoyun I; Yılmaz G
Int Ophthalmol; 2022 Sep; 42(9):2925-2932. PubMed ID: 35876940
[TBL] [Abstract][Full Text] [Related]
35. Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularization.
Shimada N; Ohno-Matsui K; Hayashi K; Yoshida T; Tokoro T; Mochizuki M
Jpn J Ophthalmol; 2011 Jul; 55(4):378-382. PubMed ID: 21617959
[TBL] [Abstract][Full Text] [Related]
36. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
37. [Anti-VEGF therapy for juxtafoveolar choroidal neovessels in people with high myopia: about a case].
Moustaine MO; Dellali F; Husseini AE; Hirsch AL
Pan Afr Med J; 2017; 26():98. PubMed ID: 28491229
[TBL] [Abstract][Full Text] [Related]
38. Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management.
Cheung CMG; Arnold JJ; Holz FG; Park KH; Lai TYY; Larsen M; Mitchell P; Ohno-Matsui K; Chen SJ; Wolf S; Wong TY
Ophthalmology; 2017 Nov; 124(11):1690-1711. PubMed ID: 28655539
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Efficacy of Intravitreal Ranibizumab and Aflibercept in Eyes with Myopic Choroidal Neovascularization: 24-Month Follow-Up.
Korol A; Kustryn T; Zadorozhnyy O; Pasyechnikova N; Kozak I
J Ocul Pharmacol Ther; 2020 Mar; 36(2):122-125. PubMed ID: 31755809
[No Abstract] [Full Text] [Related]
40. Progression of myopic maculopathy after treatment of choroidal neovascularization.
Farinha CL; Baltar AS; Nunes SG; Figueira JP; Pires IA; Cachulo ML; Silva RM
Ophthalmologica; 2014; 231(4):211-20. PubMed ID: 24662778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
